Symbols / RZLT $3.33 +1.52% Rezolute, Inc.

Healthcare • Biotechnology • United States • NCM
RZLT Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. Its lead clinical asset is ersodetug, an intravenously administered human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder, as well as for the treatment of hypoglycemia; and clinical trials of ersodetug for tumor hyperinsulinism. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California.

Fundamentals
Scroll to Statements
Market Cap 318.67M Enterprise Value 182.24M Income -84.23M Sales — Book/sh 1.23 Cash/sh 1.39
Dividend Yield — Payout 0.00% Employees 75 IPO — P/E — Forward P/E -4.87
PEG — P/S — P/B 2.70 P/C — EV/EBITDA -2.06 EV/Sales —
Quick Ratio 13.95 Current Ratio 14.18 Debt/Eq 1.00 LT Debt/Eq — EPS (ttm) -0.93 EPS next Y -0.68
EPS Growth — Revenue Growth — Earnings 2026-05-12 ROA -44.09% ROE -74.02% ROIC —
Gross Margin 0.00% Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 95.70M Shs Float 65.46M Short Float 21.07%
Short Ratio 4.03 Short Interest — 52W High 11.46 52W Low 1.07 Beta 0.66 Avg Volume 2.63M
Volume 1.65M Target Price $5.12 Recom None Prev Close $3.28 Price $3.33 Change 1.52%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$5.13
Mean price target
2. Current target
$3.33
Latest analyst target
3. DCF / Fair value
$-8.68
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$3.33
Low
$4.00
High
$6.00
Mean
$5.13

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-25 up Wedbush Neutral → Outperform $5
2026-01-08 main Wedbush Neutral → Neutral $2
2026-01-08 reit BTIG Buy → Buy $5
2025-12-12 main Guggenheim Buy → Buy $6
2025-12-12 main HC Wainwright & Co. Buy → Buy $5
2025-11-20 reit BTIG Buy → Buy $17
2025-10-29 main Citizens Market Outperform → Market Outperform $17
2025-09-22 reit Guggenheim Buy → Buy $15
2025-09-19 main Maxim Group Buy → Buy $20
2025-09-18 reit BTIG Buy → Buy $17
2025-09-03 reit HC Wainwright & Co. Buy → Buy $14
2025-04-28 reit HC Wainwright & Co. Buy → Buy $14
2025-02-13 reit HC Wainwright & Co. Buy → Buy $14
2025-02-13 main JMP Securities Market Outperform → Market Outperform $9
2025-02-10 reit Guggenheim Buy → Buy —
2025-02-05 reit HC Wainwright & Co. Buy → Buy $14
2024-11-08 reit HC Wainwright & Co. Buy → Buy $14
2024-11-05 init Wedbush — → Outperform $12
2024-08-06 main Maxim Group Buy → Buy $10
2024-08-06 reit HC Wainwright & Co. Buy → Buy $14
News
RSS: Latest RZLT news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-30 EVANS DARON Chief Financial Officer — 10,000 $2.85 $28,500
2025-12-16 ROBERTS BRIAN KENNETH Officer — 28,000 $1.70 $47,600
2025-12-16 HOGENHUIS WLADIMIR Director — 5,650 $1.69 $9,548
2025-12-15 KARNAWAT SUNIL RATILAL Officer — 12,100 $1.60 $19,599
2025-12-15 ELAM NEVAN C Chief Executive Officer — 32,000 $1.59 $50,880
2025-12-15 EVANS DARON Chief Financial Officer — 45,000 $1.77 $79,578
2025-11-19 ROBERTS BRIAN KENNETH Officer — 123,000 $0.00 $0
2025-11-19 KARNAWAT SUNIL RATILAL Officer — 32,000 $0.00 $0
2025-11-19 ELAM NEVAN C Chief Executive Officer — 317,000 $0.00 $0
2025-11-19 LABRUCHERIE GILBERT M JR Director — 21,000 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
79.89
+13.45%
70.42
+25.78%
55.99
+34.55%
41.61
Research And Development
61.53
+10.38%
55.74
+27.23%
43.81
+34.87%
32.49
Selling General And Administration
18.37
+25.12%
14.68
+20.56%
12.18
+30.14%
9.36
General And Administrative Expense
18.37
+25.12%
14.68
+20.56%
12.18
+30.14%
9.36
Salaries And Wages
—
—
—
—
Other Gand A
18.37
+25.12%
14.68
+20.56%
12.18
+30.14%
9.36
Other Operating Expenses
—
—
—
-0.23
Total Expenses
79.89
+13.45%
70.42
+25.78%
55.99
+34.55%
41.61
Operating Income
-79.89
-13.45%
-70.42
-25.78%
-55.99
-34.55%
-41.61
Total Operating Income As Reported
-79.89
-13.45%
-70.42
-25.78%
-55.99
-33.81%
-41.84
EBITDA
-79.86
-13.46%
-70.39
-25.78%
-55.96
-42.61%
-39.24
Normalized EBITDA
-79.86
-18.35%
-67.48
-20.60%
-55.95
-34.77%
-41.52
Reconciled Depreciation
0.03
-13.89%
0.04
+20.00%
0.03
+130.77%
0.01
EBIT
-79.89
-13.45%
-70.42
-25.78%
-55.99
-42.64%
-39.25
Total Unusual Items
—
-2.91
-58020.00%
-0.01
-100.22%
2.28
Total Unusual Items Excluding Goodwill
—
-2.91
-58020.00%
-0.01
-100.22%
2.28
Special Income Charges
—
—
0.00
+100.00%
-1.77
Other Special Charges
—
—
—
1.77
Net Income
-74.41
-8.70%
-68.46
-32.19%
-51.79
-26.13%
-41.06
Pretax Income
-74.41
-8.70%
-68.46
-32.19%
-51.79
-26.13%
-41.06
Net Non Operating Interest Income Expense
5.48
+12.57%
4.87
+15.73%
4.21
+343.66%
-1.73
Interest Expense Non Operating
—
—
0.00
-100.00%
1.81
Net Interest Income
5.48
+12.57%
4.87
+15.73%
4.21
+343.66%
-1.73
Interest Expense
—
—
0.00
-100.00%
1.81
Interest Income Non Operating
5.48
+12.57%
4.87
+15.73%
4.21
+5160.00%
0.08
Interest Income
5.48
+12.57%
4.87
+15.73%
4.21
+5160.00%
0.08
Other Income Expense
—
-2.91
-58020.00%
-0.01
-100.22%
2.28
Other Non Operating Income Expenses
—
—
—
—
Gain On Sale Of Security
—
-2.91
-58020.00%
-0.01
-100.12%
4.05
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-74.41
-8.70%
-68.46
-32.19%
-51.79
-26.13%
-41.06
Net Income From Continuing Operation Net Minority Interest
-74.41
-8.70%
-68.46
-32.19%
-51.79
-26.13%
-41.06
Net Income From Continuing And Discontinued Operation
-74.41
-8.70%
-68.46
-32.19%
-51.79
-26.13%
-41.06
Net Income Continuous Operations
-74.41
-8.70%
-68.46
-32.19%
-51.79
-26.13%
-41.06
Normalized Income
-74.41
-13.51%
-65.55
-26.59%
-51.78
-19.48%
-43.34
Net Income Common Stockholders
-74.41
-8.70%
-68.46
-32.19%
-51.79
-26.13%
-41.06
Diluted EPS
-0.98
+26.32%
-1.33
-31.68%
-1.01
+56.47%
-2.32
Basic EPS
-0.98
+26.32%
-1.33
-31.68%
-1.01
+55.31%
-2.26
Basic Average Shares
76.00
+47.67%
51.47
+0.55%
51.19
+181.29%
18.20
Diluted Average Shares
76.00
+47.67%
51.47
+0.55%
51.19
+162.67%
19.49
Diluted NI Availto Com Stockholders
-74.41
-8.70%
-68.46
-32.19%
-51.79
-14.75%
-45.13
Average Dilution Earnings
—
—
0.00
+100.00%
-4.07
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total Assets
175.49
+32.21%
132.74
+7.29%
123.72
-18.83%
152.42
Current Assets
171.15
+33.03%
128.65
+22.63%
104.91
-31.03%
152.10
Cash Cash Equivalents And Short Term Investments
167.86
+32.30%
126.87
+24.51%
101.90
-32.25%
150.41
Cash And Cash Equivalents
94.11
+33.68%
70.40
+338.99%
16.04
-89.34%
150.41
Cash Equivalents
89.06
+45.40%
61.25
+515.88%
9.95
—
Cash Financial
5.05
-44.77%
9.15
+50.17%
6.09
—
Other Short Term Investments
73.75
+30.58%
56.48
-34.22%
85.86
0.00
Prepaid Assets
—
—
3.01
+77.92%
1.69
Other Current Assets
3.29
+84.77%
1.78
-40.98%
3.01
+77.92%
1.69
Total Non Current Assets
4.34
+6.39%
4.08
-78.29%
18.81
+5852.85%
0.32
Net PPE
1.42
-28.39%
1.98
-9.58%
2.19
+1205.36%
0.17
Gross PPE
1.56
-25.45%
2.09
-7.69%
2.26
+988.46%
0.21
Accumulated Depreciation
-0.14
-28.97%
-0.11
-50.70%
-0.07
-77.50%
-0.04
Properties
0.00
0.00
0.00
0.00
Buildings And Improvements
1.35
-28.30%
1.88
-8.47%
2.05
+1251.32%
0.15
Machinery Furniture Equipment
0.21
+0.00%
0.21
+0.00%
0.21
+275.00%
0.06
Other Properties
—
—
—
—
Investments And Advances
0.00
-100.00%
0.26
-98.40%
16.47
0.00
Non Current Deferred Assets
—
—
—
—
Non Current Prepaid Assets
—
—
0.15
+0.00%
0.15
Other Non Current Assets
2.92
+59.14%
1.84
+1141.89%
0.15
+0.00%
0.15
Total Liabilities Net Minority Interest
13.36
+13.88%
11.73
+55.44%
7.55
+155.99%
2.95
Current Liabilities
11.91
+24.01%
9.61
+84.73%
5.20
+111.21%
2.46
Payables And Accrued Expenses
9.01
+24.70%
7.23
+91.37%
3.78
+60.41%
2.35
Payables
5.81
+18.53%
4.90
+49.92%
3.27
+188.78%
1.13
Accounts Payable
5.81
+18.53%
4.90
+49.92%
3.27
+188.78%
1.13
Current Accrued Expenses
3.20
+37.72%
2.33
+358.58%
0.51
-58.51%
1.22
Pensionand Other Post Retirement Benefit Plans Current
2.27
+25.22%
1.81
+105.21%
0.88
0.00
Current Debt And Capital Lease Obligation
0.63
+11.27%
0.57
+4.99%
0.54
+400.93%
0.11
Current Capital Lease Obligation
0.63
+11.27%
0.57
+4.99%
0.54
+400.93%
0.11
Total Non Current Liabilities Net Minority Interest
1.45
-31.81%
2.13
-9.41%
2.35
+382.34%
0.49
Long Term Debt And Capital Lease Obligation
0.98
-40.78%
1.66
-14.30%
1.94
+2321.25%
0.08
Long Term Debt
—
—
—
—
Long Term Capital Lease Obligation
0.98
-40.78%
1.66
-14.30%
1.94
+2321.25%
0.08
Tradeand Other Payables Non Current
—
—
—
—
Stockholders Equity
162.13
+33.99%
121.00
+4.16%
116.17
-22.28%
149.47
Common Stock Equity
162.13
+33.99%
121.00
+4.16%
116.17
-22.28%
149.47
Capital Stock
0.09
+64.15%
0.05
+43.24%
0.04
+8.82%
0.03
Common Stock
0.09
+64.15%
0.05
+43.24%
0.04
+8.82%
0.03
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
87.00
+63.39%
53.25
+44.58%
36.83
+9.66%
33.58
Ordinary Shares Number
87.00
+63.39%
53.25
+44.58%
36.83
+9.66%
33.58
Additional Paid In Capital
565.90
+25.62%
450.47
+19.34%
377.47
+5.25%
358.63
Retained Earnings
-403.86
-22.59%
-329.44
-26.23%
-260.99
-24.76%
-209.20
Gains Losses Not Affecting Retained Earnings
-0.01
+91.14%
-0.08
+77.49%
-0.35
0.00
Other Equity Adjustments
-0.01
+91.14%
-0.08
+77.49%
-0.35
—
Total Equity Gross Minority Interest
162.13
+33.99%
121.00
+4.16%
116.17
-22.28%
149.47
Total Capitalization
162.13
+33.99%
121.00
+4.16%
116.17
-22.28%
149.47
Working Capital
159.23
+33.76%
119.05
+19.39%
99.71
-33.37%
149.64
Invested Capital
162.13
+33.99%
121.00
+4.16%
116.17
-22.28%
149.47
Total Debt
1.61
-27.51%
2.23
-10.09%
2.48
+1218.09%
0.19
Capital Lease Obligations
1.61
-27.51%
2.23
-10.09%
2.48
+1218.09%
0.19
Net Tangible Assets
162.13
+33.99%
121.00
+4.16%
116.17
-22.28%
149.47
Tangible Book Value
162.13
+33.99%
121.00
+4.16%
116.17
-22.28%
149.47
Derivative Product Liabilities
0.47
+0.00%
0.47
+13.59%
0.41
+1.23%
0.41
Held To Maturity Securities
0.00
-100.00%
0.26
-98.40%
16.47
0.00
Investmentin Financial Assets
0.00
-100.00%
0.26
-98.40%
16.47
0.00
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Operating Cash Flow
-69.08
-20.41%
-57.37
-28.97%
-44.48
-12.28%
-39.62
Cash Flow From Continuing Operating Activities
-69.08
-20.41%
-57.37
-28.97%
-44.48
-12.28%
-39.62
Net Income From Continuing Operations
-74.41
-8.70%
-68.46
-32.19%
-51.79
-26.13%
-41.06
Depreciation Amortization Depletion
0.03
-13.89%
0.04
+20.00%
0.03
+130.77%
0.01
Depreciation
0.03
-13.89%
0.04
+20.00%
0.03
—
Depreciation And Amortization
0.03
-13.89%
0.04
+20.00%
0.03
+130.77%
0.01
Other Non Cash Items
0.53
+1.14%
0.53
+49.43%
0.35
-47.23%
0.67
Stock Based Compensation
7.12
-3.25%
7.36
+1.27%
7.27
+97.23%
3.69
Asset Impairment Charge
—
—
—
—
Operating Gains Losses
—
2.91
+58020.00%
0.01
+100.22%
-2.28
Gain Loss On Investment Securities
—
2.91
+58020.00%
0.01
+100.12%
-4.05
Change In Working Capital
0.05
-98.48%
3.10
+203.62%
1.02
+259.03%
-0.64
Change In Prepaid Assets
-2.10
-1524.03%
-0.13
+90.23%
-1.32
-53.49%
-0.86
Change In Payables And Accrued Expense
2.14
-33.66%
3.23
+37.93%
2.34
+973.85%
0.22
Change In Accrued Expense
0.72
-66.40%
2.15
+946.83%
0.20
-10.48%
0.23
Change In Payable
1.42
+31.21%
1.08
-49.30%
2.14
+19518.18%
-0.01
Change In Account Payable
1.42
+31.21%
1.08
-49.30%
2.14
+19518.18%
-0.01
Investing Cash Flow
-14.54
-129.86%
48.70
+148.00%
-101.46
0.00
Cash Flow From Continuing Investing Activities
-14.54
-129.86%
48.70
+148.00%
-101.46
0.00
Net PPE Purchase And Sale
—
0.00
+100.00%
-0.15
0.00
Purchase Of PPE
—
0.00
+100.00%
-0.15
0.00
Capital Expenditure
—
—
-0.15
—
Net Investment Purchase And Sale
-14.54
-129.86%
48.70
+148.07%
-101.31
0.00
Purchase Of Investment
-128.14
-92.98%
-66.40
+38.12%
-107.31
0.00
Sale Of Investment
113.60
-1.30%
115.10
+1818.33%
6.00
0.00
Financing Cash Flow
107.33
+70.28%
63.03
+444.72%
11.57
-92.23%
148.98
Cash Flow From Continuing Financing Activities
107.33
+70.28%
63.03
+444.72%
11.57
-92.23%
148.98
Net Issuance Payments Of Debt
—
—
0.00
+100.00%
-16.01
Issuance Of Debt
—
—
—
0.00
Repayment Of Debt
—
—
0.00
+100.00%
-16.01
Long Term Debt Issuance
—
—
—
0.00
Long Term Debt Payments
—
—
0.00
+100.00%
-16.01
Net Long Term Debt Issuance
—
—
0.00
+100.00%
-16.01
Net Common Stock Issuance
86.40
+76.27%
49.02
+297.54%
12.33
-89.96%
122.82
Proceeds From Stock Option Exercised
21.98
+53.40%
14.33
0.00
-100.00%
46.14
Net Other Financing Charges
-1.06
-233.02%
-0.32
+58.10%
-0.76
+80.88%
-3.97
Changes In Cash
23.71
-56.38%
54.36
+140.45%
-134.37
-222.87%
109.36
Beginning Cash Position
70.40
+338.99%
16.04
-89.34%
150.41
+266.43%
41.05
End Cash Position
94.11
+33.68%
70.40
+338.99%
16.04
-89.34%
150.41
Free Cash Flow
-69.08
-20.41%
-57.37
-28.53%
-44.63
-12.67%
-39.62
Interest Paid Supplemental Data
0.00
0.00
0.00
-100.00%
1.49
Income Tax Paid Supplemental Data
0.00
0.00
0.00
0.00
Amortization Of Securities
-2.39
+15.62%
-2.84
-107.08%
-1.37
0.00
Common Stock Issuance
86.40
+76.27%
49.02
+297.54%
12.33
-89.96%
122.82
Issuance Of Capital Stock
86.40
+76.27%
49.02
+297.54%
12.33
-89.96%
122.82
Net Preferred Stock Issuance
—
—
—
10.78
Preferred Stock Issuance
—
—
—
10.78
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category